Ranbaxy Exits Pfizer's Suit Over Generic Rapamune
Ranbaxy Laboratories Ltd. on Monday exited a patent infringement suit launched by Pfizer Inc. against it and Watson Pharmaceuticals Inc. in Delaware federal court in response to abbreviated new drug applications...To view the full article, register now.
Already a subscriber? Click here to view full article